×
MOTS-C 10mg Research Peptide NAD+ 500mg Research Compound
First Order Offer
RMJS 1,000+ researchers subscribed

Get 10% Off
Your First Order

Purity-verified research compounds with third-party COAs. Fast shipping from Colorado.

Order before 12 PM MST — ships same day
99%+ Purity Secure Checkout COA Verified
No thanks, I'll pay full price No spam. Unsubscribe anytime. For research use only.

You're In!

Check your email for your exclusive 10% discount code.

Shop Now
🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado

GLP-1 Receptor Agonists in Research: From Semaglutide to Next-Generation Peptides

Disclaimer: All products mentioned in this article are intended strictly for laboratory research and in vitro use only. They are not for human or veterinary consumption, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. The landscape of metabolic research has been fundamentally transformed by the […]

Vector Team

Retatrutide: The Triple-Agonist Peptide Reshaping Metabolic Research in 2026

The landscape of metabolic peptide research has evolved rapidly from single-receptor targets to complex multi-agonist compounds. While semaglutide and tirzepatide have dominated clinical discussions in recent years, retatrutide has emerged in 2026 as a revolutionary subject of investigation. As a “triple-agonist” peptide, retatrutide targets three distinct hormone pathways simultaneously, demonstrating unprecedented metabolic effects in clinical […]

Vector Team